Found 6 matching trials
Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults PHASE1 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Meridian Clinical Research
Learn More & Join Trial
Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older PHASE1 VAM00001 is a Phase I/II, randomized, modified double-blind, multi-center s...
Show More Location
Centricity Research-Mesa Site Number : 8400006
Learn More & Join Trial
Recombinant H7 Hemagglutinin Influenza Vaccine Trial PHASE1 Recombinant H7 (rH7) vaccine has been shown to be poorly immunogenic in pre...
Show More Location
Flinders University
Learn More & Join Trial
Panblok H7 Vaccine Adjuvanted With AS03 or MF59 PHASE2 The main purpose of this study is to assess the safety and ability of a Pan...
Show More Location
Johnson County Clin-Trials
Learn More & Join Trial
Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older PHASE1 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Coastal Clinical Research
Learn More & Join Trial
Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults PHASE1 The purpose of this study is to investigate the safety and immunogenicity o...
Show More Location
Vince and Associates Clinical Research
Learn More & Join Trial